|
US6150584A
(en)
*
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
*
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5462856A
(en)
|
1990-07-19 |
1995-10-31 |
Bunsen Rush Laboratories, Inc. |
Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
|
|
US5440021A
(en)
*
|
1991-03-29 |
1995-08-08 |
Chuntharapai; Anan |
Antibodies to human IL-8 type B receptor
|
|
US5314992A
(en)
*
|
1991-11-25 |
1994-05-24 |
Trustees Of Dartmouth College |
Lipocortin-1 receptor protein and its uses
|
|
US5817310A
(en)
*
|
1991-12-02 |
1998-10-06 |
Cor Therapeutics, Inc. |
Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
|
|
JP3664176B2
(ja)
|
1992-11-10 |
2005-06-22 |
ジェネンテック・インコーポレーテッド |
Ｃ−ｃ ｃｋｒ−１，ｃ−ｃケモカインレセプター
|
|
CA2128208C
(en)
|
1992-11-17 |
2004-01-06 |
Ronald Godiska |
Novel seven transmembrane receptors
|
|
US5652133A
(en)
*
|
1993-01-28 |
1997-07-29 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor
|
|
ES2107698T3
(es)
|
1993-02-20 |
1997-12-01 |
Hoechst Ag |
Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento, como inhibidores del intercambio celular de na+/h+ o como agente de diagnostico, asi como medicamento que las contiene.
|
|
US5739103A
(en)
|
1993-11-12 |
1998-04-14 |
Dana-Farber Cancer Institute |
Chemokine N-terminal deletion mutations
|
|
WO1995019436A1
(en)
|
1994-01-13 |
1995-07-20 |
The Regents Of The University Of California |
Mammalian monocyte chemoattractant protein receptors
|
|
DE4408212A1
(de)
|
1994-03-11 |
1995-09-14 |
Bayer Ag |
5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
|
|
US6806061B1
(en)
|
1995-01-19 |
2004-10-19 |
Children's Medical Center Corporation |
G protein-coupled receptor gene and methods of use therefor
|
|
US6537764B1
(en)
|
1995-01-19 |
2003-03-25 |
Children's Medical Center Corporation |
Method of identifying inhibitors of C—C chemokine receptor 3
|
|
GB9501683D0
(en)
|
1995-01-27 |
1995-03-15 |
Glaxo Group Ltd |
Substances and their uses
|
|
JPH11507501A
(ja)
*
|
1995-06-05 |
1999-07-06 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
ヒトｇタンパク質レセプターｈｇｂｅｒ３２
|
|
JPH10510719A
(ja)
|
1995-06-06 |
1998-10-20 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
ヒトｇタンパク質ケモカインレセプターｈｄｇｎｒ１０
|
|
US6743594B1
(en)
*
|
1995-06-06 |
2004-06-01 |
Human Genome Sciences, Inc. |
Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
|
|
US6025154A
(en)
*
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
|
US7265201B1
(en)
|
1995-06-23 |
2007-09-04 |
Millennium Pharmaceuticals, Inc. |
Human chemotactic cytokine
|
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
|
AU1141997A
(en)
|
1995-11-30 |
1997-06-19 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
C-c chemokines that inhibit retrovirus infection
|
|
US6512103B1
(en)
|
1995-12-08 |
2003-01-28 |
Schering Corporation |
Mammalian chemokine reagents
|
|
US6265184B1
(en)
*
|
1995-12-20 |
2001-07-24 |
Icos Corporation |
Polynucleotides encoding chemokine receptor 88C
|
|
CA2242908A1
(en)
|
1996-01-11 |
1997-07-17 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor hsatu68
|
|
EP0854918A1
(en)
|
1996-01-30 |
1998-07-29 |
The National Institutes of Health |
Cells expressing both human cd4 and cxcr4
|
|
WO1997032019A2
(en)
*
|
1996-03-01 |
1997-09-04 |
Euroscreen S.A. |
C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
|
|
EP0906339A2
(en)
|
1996-03-27 |
1999-04-07 |
NG, Gordon, Y., K. |
Receptor and transporter antagonists
|
|
US6344545B1
(en)
*
|
1996-06-14 |
2002-02-05 |
Progenics Pharmaceuticals, Inc. |
Method for preventing HIV-1 infection of CD4+ cells
|
|
US6107019A
(en)
*
|
1996-06-14 |
2000-08-22 |
Progenics Pharmaceuticals, Inc. |
Method for preventing HIV-1 infection of CD4+ cells
|
|
AU728512B2
(en)
|
1996-04-02 |
2001-01-11 |
Progenics Pharmaceuticals, Inc. |
Method for preventing HIV-1 infection of CD4+ cells
|
|
EP0906424A2
(en)
|
1996-04-26 |
1999-04-07 |
Incyte Pharmaceuticals, Inc. |
Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr]
|
|
AU2775397A
(en)
|
1996-04-30 |
1997-11-19 |
Wolf-Georg Forssmann |
Cc-type chemokines
|
|
US5939320A
(en)
*
|
1996-05-20 |
1999-08-17 |
New York University |
G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
|
|
US6258527B1
(en)
*
|
1996-05-20 |
2001-07-10 |
The Aaron Diamond Aids Research Center |
Methods of identifying g-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
|
|
WO1997045543A2
(en)
|
1996-05-28 |
1997-12-04 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health |
Cc chemokine receptor 5, antibodies thereto, transgenic animals
|
|
ES2270461T3
(es)
|
1996-06-03 |
2007-04-01 |
United Biomedical, Inc. |
Anticuerpos contra un complejo de cd4 y un dominio receptor de quemoquina, y sus usos contra las infecciones de vih.
|
|
US5961976A
(en)
*
|
1996-06-03 |
1999-10-05 |
United Biomedical, Inc. |
Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV
|
|
AU735460B2
(en)
|
1996-06-14 |
2001-07-12 |
Aaron Diamond Aids Research Center, The |
Uses of a chemokine receptor for inhibiting HIV-1 infection
|
|
WO1997049424A1
(en)
|
1996-06-25 |
1997-12-31 |
The Trustees Of The University Of Pennsylvania |
Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
|
|
US5994515A
(en)
*
|
1996-06-25 |
1999-11-30 |
Trustees Of The University Of Pennsylvania |
Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
|
|
WO1998000535A2
(en)
|
1996-06-28 |
1998-01-08 |
Dana-Farber Cancer Institute |
Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection
|
|
US5928881A
(en)
*
|
1996-07-11 |
1999-07-27 |
Smithkline Beecham Corporation |
Method of identifying agonists and antagonist for CC-CKR5 receptor
|
|
CA2259927A1
(en)
|
1996-07-12 |
1998-01-22 |
Leukosite, Inc. |
Chemokine receptor antagonists and methods of use therefor
|
|
US6057102A
(en)
*
|
1996-08-08 |
2000-05-02 |
The Aaron Diamond Aids Research Center |
HIV coreceptor mutants
|
|
WO1998005798A1
(en)
|
1996-08-08 |
1998-02-12 |
The Aaron Diamond Aids Research Center |
Hiv coreceptor mutants
|
|
ATE360689T1
(de)
|
1996-09-10 |
2007-05-15 |
Kocher Theodor Inst |
Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
|
|
US6388055B1
(en)
|
1996-10-03 |
2002-05-14 |
Smithkline Beecham Corporation |
Mouse CC-CKR5 receptor polypeptide
|
|
AU731975B2
(en)
|
1996-10-09 |
2001-04-12 |
Children's Medical Center Corporation |
GP120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting HIV infection
|
|
US5939538A
(en)
|
1996-10-25 |
1999-08-17 |
Immusol Incorporated |
Methods and compositions for inhibiting HIV infection of cells by cleaving HIV co-receptor RNA
|
|
US6528625B1
(en)
*
|
1996-10-28 |
2003-03-04 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR5 antibodies and kits comprising same
|
|
EP0954612A2
(en)
|
1996-11-06 |
1999-11-10 |
Sequenom, Inc. |
Dna diagnostics based on mass spectrometry
|
|
US5962462A
(en)
*
|
1996-12-13 |
1999-10-05 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
WO1998025604A1
(en)
|
1996-12-13 |
1998-06-18 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
AU5522498A
(en)
|
1996-12-13 |
1998-07-03 |
Merck & Co., Inc. |
Substituted aryl piperazines as modulators of chemokine receptor activity
|
|
WO1998025605A1
(en)
|
1996-12-13 |
1998-06-18 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
AU5812498A
(en)
|
1996-12-20 |
1998-07-17 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
US5919776A
(en)
*
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
AR011057A1
(es)
|
1997-01-08 |
2000-08-02 |
Smithkline Beecham Corp |
Uso de bis-acridinas sustituidas y compuestos afines para la preparacion de medicamentos y dichos compuestos
|
|
US5798206A
(en)
*
|
1997-01-10 |
1998-08-25 |
New York Blood Center |
Methods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to a chemokine receptor
|
|
JP2001508798A
(ja)
|
1997-01-21 |
2001-07-03 |
メルク エンド カンパニー インコーポレーテッド |
ケモカインレセプター活性のモジュレーターとしての３，３−二置換ピペリジン類
|
|
RU2126048C1
(ru)
|
1997-01-28 |
1999-02-10 |
Институт молекулярной генетики РАН |
Способ определения генетической устойчивости обследуемых к инфицированию вирусом иммунодефицита человека первого типа (вич-1)
|
|
AU6271598A
(en)
|
1997-02-06 |
1998-08-26 |
Epoch Pharmaceuticals, Inc. |
Targeted modification of the ccr-5 gene
|
|
US6100387A
(en)
|
1997-02-28 |
2000-08-08 |
Genetics Institute, Inc. |
Chimeric polypeptides containing chemokine domains
|
|
US6214540B1
(en)
|
1997-03-26 |
2001-04-10 |
University Of Maryland Biotechnology Institute |
Chemokines that inhibit immunodeficiency virus infection and methods based thereon
|
|
CA2285384C
(en)
|
1997-03-28 |
2012-10-16 |
Epitope, Inc. |
Simultaneous collection of dna and non-nucleic analytes from oral fluids
|
|
IT1291353B1
(it)
|
1997-05-12 |
1999-01-07 |
San Raffaele Centro Fond |
Peptidi con attivita' antivirale
|
|
US6153431A
(en)
*
|
1997-05-30 |
2000-11-28 |
Fond Mondiale Rech & Prev Sida |
Human immunodeficiency virus co-receptor variants associated with resistance to virus infection
|
|
FR2764387B1
(fr)
|
1997-06-05 |
1999-07-23 |
Centre Nat Rech Scient |
Utilisation d'une proteine fluorescente pour la detection d'interactions entre une proteine cible et son ligand
|
|
WO1998058536A1
(en)
|
1997-06-23 |
1998-12-30 |
J. David Gladstone Institutes |
Transgenic rabbits expressing cd4 and chemokine receptor
|
|
WO1998058966A1
(en)
|
1997-06-24 |
1998-12-30 |
Norman Godin |
A composition for specific immunoprotection and method for obtaining said composition
|
|
ZA985542B
(en)
|
1997-07-03 |
1999-04-07 |
Smithkline Beecham Corp |
Substituted benzanilides as CCR5 receptor ligands antiinflammatory agents and antiviral agents
|
|
WO1999004794A1
(en)
|
1997-07-25 |
1999-02-04 |
Merck & Co., Inc. |
Cyclic amine modulators of chemokine receptor activity
|
|
AU8669598A
(en)
|
1997-07-29 |
1999-02-22 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Chemokine receptor ccr8 dna and uses thereof
|
|
US6019979A
(en)
|
1997-08-15 |
2000-02-01 |
The Picower Institute For Medical Research |
Anti-viral treatment with pertussis toxin B oligomer
|
|
EP1009405A4
(en)
|
1997-08-28 |
2001-05-09 |
Merck & Co Inc |
PAYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
|
|
US6287568B1
(en)
|
1997-09-09 |
2001-09-11 |
The Trustees Of Columbia University In The City Of New York |
Methods relating to immunogenic dextran-protein conjugates
|
|
US6204024B1
(en)
|
1997-09-12 |
2001-03-20 |
Akzo Nobel N.V. |
CCR5 RNA transcription based amplification assay
|
|
WO1999014378A2
(en)
|
1997-09-19 |
1999-03-25 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods using interleukin 4 to treat hiv infection
|
|
AR013669A1
(es)
|
1997-10-07 |
2001-01-10 |
Smithkline Beecham Corp |
Compuestos y metodos
|
|
WO1999023253A1
(en)
|
1997-10-30 |
1999-05-14 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Stromal cell derived factor-1 (sdf-1) and method of use for diagnostic and prognostic indicator of aids pathogenesis
|
|
WO1999023107A1
(en)
|
1997-10-31 |
1999-05-14 |
Maxygen, Incorporated |
Modification of virus tropism and host range by viral genome shuffling
|
|
WO1999024553A2
(en)
|
1997-11-10 |
1999-05-20 |
The Trustees Of Columbia University In The City Of New York |
X-ray crystal comprising hiv-1 gp120
|
|
WO1999024065A1
(en)
|
1997-11-10 |
1999-05-20 |
The Trustees Of Columbia University In The City Of New York |
COMPOUNDS INHIBITING CD4-gp120 INTERACTION AND USES THEREOF
|
|
FR2771423A1
(fr)
|
1997-11-21 |
1999-05-28 |
Transgene Sa |
Vecteurs permettant d'inhiber ou retarder la liaison d'un virus d'immunodeficience et/ou sa penetration dans une cellule cible
|
|
WO1999028474A2
(en)
|
1997-12-01 |
1999-06-10 |
The Government Of The United States Of America, Represented By The Secretary Of Health And Human Services |
Chemokine variants and methods of use
|
|
WO1999027939A1
(en)
|
1997-12-04 |
1999-06-10 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
|
|
US6013644A
(en)
*
|
1997-12-12 |
2000-01-11 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
|
AU2004199A
(en)
|
1997-12-19 |
1999-07-12 |
Immunex Corporation |
Method for reducing susceptibility to hiv infection
|
|
EP1039899A2
(en)
|
1997-12-19 |
2000-10-04 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative
|
|
CA2316447C
(en)
|
1997-12-23 |
2009-07-28 |
Fondazione Centro San Raffaele Del Monte Tabor |
Rantes mutants and therapeutic applications thereof
|
|
JP4312957B2
(ja)
|
1998-01-15 |
2009-08-12 |
キングス・カレツジ・ロンドン |
Ｃｃｒ５あるいはｃｘｃｒ４を開裂するリボザイム核酸
|
|
EP1052992A1
(en)
|
1998-02-02 |
2000-11-22 |
Merck & Co., Inc. |
Cyclic amine modulators of chemokine receptor activity
|
|
ES2299242T3
(es)
|
1998-02-27 |
2008-05-16 |
The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services |
Antagonistas de los receptores copulados a proteina g.
|
|
JPH11243960A
(ja)
|
1998-03-06 |
1999-09-14 |
Shionogi & Co Ltd |
ヒトｃｃ型ケモカインエオタキシン３
|
|
US6100087A
(en)
|
1998-03-11 |
2000-08-08 |
City Of Hope |
Ribozymes targeted to human CCR5 mRNA
|
|
US6287805B1
(en)
*
|
1998-03-20 |
2001-09-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules of the protein-coupled heptahelical receptor superfamily and uses therefor
|
|
JPH11292795A
(ja)
|
1998-04-02 |
1999-10-26 |
Yamanouchi Pharmaceut Co Ltd |
Ｈｉｖコファクター抑制剤
|
|
US6383777B1
(en)
|
1998-04-16 |
2002-05-07 |
Va{Umlaut Over (N)}Derbilt University |
Methods and compositions for high yield production of eukaryotic proteins
|
|
AU4325499A
(en)
|
1998-06-01 |
1999-12-20 |
University Of Maryland Biotechnology Institute |
Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases
|
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
|
WO1999067429A1
(en)
|
1998-06-23 |
1999-12-29 |
Uab Research Foundation |
Cell-based assay for immunodeficiency virus infectivity and sensitivity
|
|
JP3495987B2
(ja)
|
1998-07-06 |
2004-02-09 |
エーロスクレーン エッス．アー． |
カルシウム結合レセプタに対するアゴニスト及び／またはアンタゴニストの高処理能率スクリーニング特性表示及び／または用量決定方法
|
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
|
WO2000006085A2
(en)
|
1998-07-28 |
2000-02-10 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
BR9912406A
(pt)
|
1998-07-28 |
2001-04-24 |
Smithkline Beecham Corp |
Compostos de anilida substituida e métodos
|
|
CA2338804A1
(en)
|
1998-07-28 |
2000-02-10 |
Smithkline Beecham Corporation |
Propenamides as ccr5 modulators
|
|
EP0979655A1
(de)
|
1998-08-01 |
2000-02-16 |
Boehringer Mannheim Gmbh |
Mittel zur Behandlung von durch RNA-Viren, wie beispielsweise HIV verursachten Infenktionen
|
|
EP1102788A4
(en)
|
1998-08-03 |
2002-08-28 |
Univ Montana |
PREVENTION AND TREATMENT OF VIRAL DISEASES
|
|
EP1102786A4
(en)
|
1998-08-03 |
2002-03-06 |
Univ East Carolina |
AGENT COMPRISING ANTISENSE OLIGONUCLEOTIDES WITH LOW ADENOSINE CONTENT, COMPOSITION, KIT AND TREATMENTS
|
|
AU5301599A
(en)
|
1998-08-20 |
2000-03-14 |
Takeda Chemical Industries Ltd. |
Quaternary ammonium salts and their use
|
|
US6475718B2
(en)
|
1998-09-08 |
2002-11-05 |
Schering Aktiengesellschaft |
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus
|
|
WO2000015785A2
(de)
|
1998-09-10 |
2000-03-23 |
Winfried Siffert |
GENVERÄNDERUNG IM GEN FÜR DIE Gβ3-UNTEREINHEIT DES HUMANEN G-PROTEINS
|
|
GB9820014D0
(en)
|
1998-09-14 |
1998-11-04 |
Cancer Res Campaign Tech |
Receptor antagonists and uses thereof
|
|
AU2001243145A1
(en)
*
|
2000-02-09 |
2001-08-20 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor (ccr5) hdgnr10
|
|
US6849163B2
(en)
|
2000-02-29 |
2005-02-01 |
Daikin Industries, Ltd. |
Method for producing tetrafluoroethylene
|
|
EP1287028A2
(en)
|
2000-06-09 |
2003-03-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
US7005503B2
(en)
*
|
2002-02-08 |
2006-02-28 |
Genetastix Corporation |
Human monoclonal antibody against coreceptors for human immunodeficiency virus
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
US20020146415A1
(en)
*
|
2001-04-06 |
2002-10-10 |
Olson William C. |
Methods for inhibiting HIV-1 infection
|
|
US7393934B2
(en)
*
|
2001-12-21 |
2008-07-01 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor (CCR5) HDGNR10
|
|
US20060083715A1
(en)
|
2002-03-12 |
2006-04-20 |
Steven Glazer |
Interferon beta-like molecules for treatment of stroke
|
|
WO2004020468A2
(en)
|
2002-08-28 |
2004-03-11 |
Maxygen Aps |
Interferon beta-like molecules for treatment of cancer
|